[Skip to Content]
[Skip to Content Landing]
JAMA Clinical Guidelines Synopsis
June NaN, 2015

Perioperative β-Blocker Therapy

Author Affiliations
  • 1University of Chicago, Chicago, Illinois
JAMA. 2015;313(24):2486-2487. doi:10.1001/jama.2015.3086

Routine use of β-blockers to prevent cardiac complications related to noncardiac surgery began in the 1990s after the publication of 2 influential randomized clinical trials (RCTs).1,2 Responding to this evidence, a 2002 ACC/AHA guideline published a strong recommendation for starting β-blockers in high-risk patients undergoing vascular surgery and stated that this was also reasonable in moderate- to high-risk patients undergoing major noncardiac surgery.

First Page Preview View Large
First page PDF preview
First page PDF preview